The FDA has approved Allergan’s ... that deal is bolting on Botox’ $3.6 billion annual sales, which are viewed as being almost invulnerable to competition – Dysport made less than a tenth ...
Botox (onabotulinumtoxinA ... Different neurotoxin brands, such as Dysport, Xeomin, Jeuveau, and Daxxify, are available on the market. Dermal fillers have become popular in recent years.